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Abstract
Background: De novo loss of function mutations in STXBP1 are a relatively common cause of epilepsy and intellectual
disability (ID). However, little is known about the types and severities of behavioural features associated with this genetic
diagnosis.
Methods: To address this, we collected systematic phenotyping data encompassing neurological, developmental, and
behavioural characteristics. Participants were 14 individuals with STXBP1-associated neurodevelopmental disorder,
ascertained from clinical genetics and neurology services UK-wide. Data was collected via standardised questionnaires
administered to parents at home, supplemented by researcher observations. To isolate discriminating phenotypes, the
STXBP1 group was compared to 33 individuals with pathogenic mutations in other ID-associated genes (ID group). To
account for the potential impact of global cognitive impairment, a secondary comparison was made to an ability-
matched subset of the ID group (low-ability ID group).
Results: The STXBP1 group demonstrated impairments across all assessed domains. In comparison to the ID group, the
STXBP1 group had more severe global adaptive impairments, fine motor difficulties, and hyperactivity. In comparison to
the low-ability ID group, severity of receptive language and social impairments discriminated the STXBP1 group. A striking
feature of the STXBP1 group, with reference to both comparison groups, was preservation of social motivation.
Conclusions: De novo mutations in STXBP1 are associated with complex and variable neurodevelopmental impairments.
Consistent features, which discriminate this disorder from other monogenic causes of ID, are severe language impairment
and difficulties managing social interactions, despite strong social motivation. Future work could explore the physiological
mechanisms linking motor, speech, and social development in this disorder. Understanding the developmental emergence
of behavioural characteristics can help to focus clinical assessment and management after genetic diagnosis, with the long-
term aim of improving outcomes for patients and families.
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Background
It is increasingly possible to identify the genetic cause of
severe neurodevelopmental disorders, with potential diag-
nostic yields now exceeding 50% [1]. For each rare genetic
cause, there is an ongoing imperative to characterise associ-
ated medical and behavioural features in order to provide
evidence-based prognostic advice, targeted family support,
and ultimately personalised interventions.
Syntaxin-binding protein 1 (STXBP1, formally known
as MUNC18-1) is part of the SEC1 family of membrane-
trafficking proteins that interact with SNARE proteins to
facilitate the docking of synaptic vesicles at presynaptic
active zones to enable neurotransmission [2]. STXBP1 is
expressed ubiquitously throughout the brain and neo-
cortex during development and postnatal life. De novo
STXBP1 variants were initially identified in five patients
as a cause of Ohtahara syndrome, also known as early in-
fantile epileptic encephalopathy [3]. Thereafter, the epilepsy
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spectrum associated with STXBP1 variants expanded to
include infantile spasms, West syndrome, Dravet syndrome,
Lennox-Gastaut syndrome, and various other types of
childhood-onset epilepsy [4–8]. The estimated prevalence
of de novo STXBP1 variants in severe childhood epilepsy is
3% [9]. In parallel, STXBP1 variants have been discovered
in individuals broadly ascertained for neurodevelopmental
disorders, with and without epilepsy [7, 10–14]. The preva-
lence of STXBP1 variants amongst individuals with un-
specified developmental disorders is 0.25–0.5% [15, 16].
Given the 1% prevalence of intellectual disability (ID), the
numbers of individuals diagnosed with STXBP1-associated
neurodevelopmental disorder will rise substantially over the
coming years.
Collation of clinical information has highlighted an asso-
ciation between STXBP1 variants and complex long-term
neurodevelopmental impairments, in patients with and
without epilepsy. Existing case series suggest that there is
considerable variability in the types and severities of neuro-
developmental problems associated with STXBP1 variants.
Reported problems include movement impairments such
as ataxia and tremor, language delay and behavioural
symptoms including hyperactivity, stereotypies, and autistic
features [7, 9, 13, 17–20]. However, despite the increasing
number of patients diagnosed with STXBP1 variants, no
study has carried out post-diagnostic, standardised assess-
ments to systematically characterise developmental and
behavioural aspects of the STXBP1-associated phenotype.
These data are necessary to provide families with valid
information about the types and severities of neurodeve-
lopmental difficulties that can be expected for an individual
diagnosed with an STXBP1 variant. Hence, the primary
aim of the current study was to describe in detail the neu-
rodevelopmental phenotype of children and adolescents
with STXBP1 variants, ascertained as broadly as possible.
The secondary aim of the study was to relate neurodeve-
lopmental characteristics associated with STXBP1 variants
to existing basic science literature, including animal models.
STXBP1 plays a role in calcium-dependent, short-term
synaptic facilitation, which may be particularly relevant to
learning [21]. STXBP1 loss of function mutations lead to
broad impairments in synaptic physiology that nonetheless
result in specific learning deficits and behavioural features.
In cultured neurons from human embryonic stem cells,
homozygous mutations impede synaptic transmission
which results in neurodegeneration, whereas heterozygous
mutations have a milder impact [21]. Homozygous knock-
out mice have shown that, despite normal brain assembly,
lack of STXBP1 expression inhibits pre-synaptic events
which leads to synaptic degeneration, neuronal apoptosis,
and early fatality [22–24]. In contrast, heterozygous
STXBP1 mouse models have reduced protein expression
and stability, but structurally normal synaptogenesis. Mice
demonstrate a seizure phenotype characterised by twitches,
jerks, and jumps which often coincided with EEG spike-
wave discharges [25]. Currently, there is no systematic,
comparative data available on the human behavioural
phenotype to verify whether behavioural results in STXBP1
mouse models [26–28] recapitulate the human disorder. To
achieve this, we have compared individuals with STXBP1
variants to participants with equivalently severe ID, to deter-
mine which if any characteristics are consistently observed
and are specific to this group. This comparison can add spe-
cificity to the prognostic information available to families
and clinicians and set hypotheses for future investigation of
molecular, neural, and cognitive mechanisms.
Methods
Participants and recruitment
Individuals who had previously been diagnosed with a
pathogenic de novo variant in STXBP1 were identified via
clinical genetics services, paediatric neurology services, and
clinical testing laboratories. Responsible clinicians were pro-
vided with a recruitment pack for each potential participant,
and 14 families volunteered to participate in the study.
Eight participants had been diagnosed with an STXBP1
variant via the Deciphering Developmental Disorders re-
search study [16], and the remainder had been diagnosed
via a clinical testing pathway. For both testing pathways,
pathogenicity of variants had been evaluated by the regional
genetics service according to ACMG guidelines and local
confirmation procedures. The same recruitment procedure
was followed for the comparison sample of individuals with
neurodevelopmental disorder associated with single nucleo-
tide variants in other ID-associated genes. Participants were
recruited with the assistance of 10 regional genetics centres.
Phenotyping assessments
All 14 participants were assessed in their homes. A stan-
dardised, study-specific, structured medical history inter-
view was conducted, followed by the Vineland Adaptive
Behaviour Scales, survey interview form [26]. Parents or
carers were also given age-appropriate questionnaires to
complete which included the Developmental Behavioural
Checklist (DBC) [27], Conners-3 short-form [28], Social
Responsiveness Scale (SRS-2) [29], and the Movement
ABC Parent Checklist [30]. The Movement Assessment
Battery for Children (MABC-2) was used to directly as-
sess participants’ manual dexterity, aiming and catching,
and balance [30]. Detailed notes and video recordings
were obtained in order to document qualitative observa-
tions of each participant.
Data completion rates
For descriptive reporting, data from all STXBP1 partici-
pants are included (n = 14) (Additional file 1). For com-
parative analyses, analysis was restricted to a consistent
STXBP1 group for whom a complete questionnaire
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dataset was available (‘STXBP1 full dataset group’, n = 8).
Partial data collection was achieved for younger partici-
pants (protocol only appropriate for ages 4 and above)
and for three participants without a fully completed par-
ent questionnaire pack.
Analysis
Raw scores from questionnaire data were standardised
to published normative data. Non-parametric compari-
sons were conducted throughout (Mann-Whitney U
statistics).
Results
Demographics of STXBP1 and comparison groups
(Table 1)
The STXBP1 group comprised 14 individuals with a con-
firmed pathogenic, de novo variant in STXBP1. The ID
comparison group comprised 33 individuals with con-
firmed pathogenic or likely pathogenic de novo or inherited
variants in other ID-associated genes (Additional file 2).
The STXBP1 full dataset and ID groups did not differ in
age, gender or socioeconomic status (SES) distributions.
On average, the STXBP1 group had more severe global
adaptive impairments than the ID comparison group
(Mann-Whitney U = 43.5, p = 0.004), with more severe def-
icits in all adaptive behaviour subscales except for gross
motor function (Table 2). To identify specific behavioural
characteristics not explained by these global impairments,
secondary analyses were carried out between the STXBP1
full dataset group and a low-ability subset of the ID com-
parison group, selected to match the range of Vineland
Adaptive Behaviour Composite scores. The STXBP1 full
dataset and low-ability ID comparison groups did not differ
in age, gender, or SES representation.
STXBP1 group—medical, neurological, and
neurodevelopmental characteristics
General health
Duration of pregnancy ranged from 32 to 42 weeks. No
abnormal ultrasounds or threatened miscarriages were
reported. However, five mothers reported persistent
vomiting throughout pregnancy. There were concerns
about foetal well-being during the birth of six of the
participants. Four participants were born by Caesarean
section. Only three cases subsequently spent time in
SCBU (with none requiring neonatal intensive care).
Three individuals were readmitted to hospital within the
first month of life for investigation of suspected seizures.
A large proportion of parents (85%) reported feeding
issues during infancy and early childhood, common
problems being reflux, choking, and difficulty moving
solids. Sleep difficulties were reported in four cases
during infancy, characterised by problems falling and
staying asleep. In two cases, sleep difficulties persisted
into adolescence.
Parents also reported a range of sensory issues with re-
gard to hearing, sight, and touch. Six parents reported
sight issues including; ptosis, misshapen eye, difficulty
focusing, excessive blinking, and long-sightedness. Three
parents reported hearing issues: one participant suffered
from recurrent ear infections, one had glue ear in both
ears, and one participant required hearing aids. A di-
verse range of sensory issues involving touch and sound
were reported in eight cases (3: touch, 3: sound, 2: touch
and sound). Three participants enjoyed sensory feedback
from sensory objects and people (e.g., hugging and rough
play), whereas two did not. One child appeared to enjoy
high-pitched sounds such as babies crying, whereas four
parents noticed that their children were averse to certain
loud sounds such as hoovers, fireworks, and weather. One
of these children had received a diagnosis of hyperacusis.
Table 1 Demographic information
Demographic measure Group
STXBP1 all (n = 14) STXBP1 full dataset (n = 8) ID all (n = 33) ID low ability (n = 8)
Age Mean (SD) 9.93 (5.837) 13.63 (2.326) 13.91 (5.553) 14.88 (3.271)
Range (years) 1–17 10–17 5–25 8–18
Gender % females(n) 71.4 (10) 62.5 (5) 51.5 (17) 62.5 (5)
SES** Median (SD, range) 6.5 (2.51, 2–10) 7 (1.96, 4–10) 6 (2.33, 1–10) 6.5 (1.98, 3–9)
Epilepsy (ever) % (n) 92.9 (13) 87.5 (7) 39.4 (13) 50 (4)
Epilepsy (current) % (n) 92.3 (12) 85 (6) 62 (8) 75 (3)
Epilepsy age of onset Mean (SD) 49.67 (67.059) 84.14 (70.115) 70.73 (76.352) 12.67 (9.866)
Range (months) 1–156 1–156 1–204 6–24
Global intellectual ability Mean (SD) 45.86 (14.992) 41.0 (12.13) 58.3 (15.661)# 48.0 (9.592)
Range 26–69 31–67 20–96 36–68
**SES calculated using ‘English Indices of Deprivation’ (2015)
#Comparison to STXBP1 full dataset group, Mann-Whitney U test, P < 0.05
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Neurological histories
Thirteen STXBP1 participants have a history of seizures,
diagnosed as epilepsy by a paediatric neurologist. The age
of seizure onset varied from just after birth to 13 years of
age. Half of the STXBP1 participants (n = 7) had a seizure
in their first year of life. Four of these participants had a
seizure within the first 2 months of life. For the remaining
six individuals with epilepsy, the age of onset of seizures
was broadly spread across childhood. Three participants
experienced their first seizure during the peripubertal
phase. The type of seizure also varied. One participant
was diagnosed with infant encephalopathy, two had tonic-
clonic seizures, and six experienced focal seizures. Seizure
phenotypes were mixed or uncertain for the remaining
participants. Epilepsy has been treated with a wide range
of anti-epileptic drugs (AEDs), the most frequently used
was levetiracetam (n = 4). Whilst seizure frequency was
generally reduced on treatment, no participant was
reported to be completely seizure free during the months
prior to research assessment. One participant experienced
infrequent seizures (approximately three between 5 and
14 years of age) but was not on medication. Four partici-
pants also experienced tremors in their hands, which were
observed by the researcher during assessments.
Table 2 Adaptive function
Vineland (standard score)
Domains
Subdomains
Groups
STXBP1 all (n = 14) STXBP1 full dataset (n = 8) ID all (n = 33) ID low ability (n = 8)
Communication Mean (SD) 42.64 (11.5) 43.38 (12.1) 59.15 (18.6)# 47.50 (7.6)
Range 30–67 33–67 21–100 38–61
Receptive Mean (SD) 4.82 (2.7) 4.75 (2.6) 8.70 (3.1)# 7.13 (1.5)#
Range 2–10 2–10 1–16 5–10
Expressive Mean (SD) 3.55 (2.7) 3.38 (2.8) 6.88 (4.0)# 3.00 (1.9)
Range 1–8 1–8 1–17 1–6
Written Mean (SD) 5.55 (1.8) 5.38 (1.8) 7.97 (3.4)# 5.88 (1.0)
Range 4–9 4–9 3–20 5–8
Daily living skills Mean (SD) 45.57 (19.7) 38.38 (15.5) 57.36 (18.2)# 43.00 (13.3)
Range 25–77 25–73 21–98 30–71
Personal Mean (SD) 4.71 (4.5) 2.88 (3.8) 6.18 (4.3)# 2.75 (2.6)
Range 1–12 1–12 1–19 1–8
Domestic Mean (SD) 6.43 (4.3) 4.38 (3.3) 8.73 (3.8)# 5.63 (3.3)
Range 2–13 2–12 3–17 3–13
Community Mean (SD) 4.86 (3.9) 3.00 (1.9) 6.18 (3.6)# 3.88 (2.6)
Range 1–12 1–7 1–13 1–9
Socialisation Mean (SD) 52.29 (12.1) 47.75 (8.4) 63.30 (16.5)# 56.13 (9.2) #
Range 34–75 40–67 20–108 46–75
Interpersonal Mean (SD) 6.00 (3.3) 4.63 (2.1) 7.94 (3.0)# 6.63 (1.8)
Range 2–13 2–8 1–15 4–10
Play and leisure Mean (SD) 4.93 (3.4) 3.63 (3.2) 7.76 (3.6)# 5.00 (3.7)
Range 1–11 1–11 1–15 1–11
Coping skills Mean (SD) 6.79 (1.8) 6.00 (1.3) 9.30 (3.1)# 8.00 (1.3)#
Range 4–9 5–8 6–20 6–10
Motor Mean (SD) 60.43 (16.4) 63.25 (17.4) 69.03 (12.4) 62.63 (5.6)
Range 37–97 40–97 56–107 56–72
Gross Mean (SD) 8.50 (2.8) 9.63 (3.0) 9.58 (1.8) 9.00 (1.5)
Range 5–15 6–15 7–16 7–11
Fine Mean (SD) 8.29 (4.1) 8.00 (3.1) 10.09 (3.0)# 8.50 (0.9)
Range 4–17 4–14 7–20 7–10
#Comparison to STXBP1 full dataset group, Mann-Whitney U test, P < 0.05
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Developmental milestones
Thirteen participants learned to sit independently from 7 to
42months. Seven out of thirteen sat independently before
10months, which is within the normal to mildly delayed
range, whilst the remainder were clearly delayed. The youn-
gest child in the sample (1-year-old) had extremely low
muscle tone and was not able to sit independently at the
time of assessment. Four children did not learn to crawl
but ‘bum-shuffled’ or ‘bunny hopped’. Nine participants
were walking independently at the time of assessment.
However, eight acquired this skill late: between 25 and 60
months old. One participant, aged 14, could walk a few
steps but required constant support. Three participants be-
tween 1.9 and 6.8 years of age had not yet learned to walk.
Speech and language acquisition were delayed in all cases.
Eight participants currently use some verbal communica-
tion, with age of first words being between 18 and 156
months (13 years). The age of participants not currently
using verbal communication is between 1.1 and 15 years.
Of the four participants who can form simple phrases or
sentences, three of these acquired this skill late, after 5.5
years of age.
Current motor abilities
Vineland gross and fine motor subscale scores reflect
the extent of impairment and range of motor abilities
within the sample. Gross motor standardised scores
ranged between 6 and 15: from severely impaired to
average for age (maximum score 24, normative popula-
tion mean = 15, SD = 3). The participant with the highest
score could run, jump, hop, skip, and kick, throw, and
catch a ball, whereas, at age 6, the participant with the
score was unable to pull themselves to a standing pos-
ition. Similarly, fine motor standard scores ranged from
4 to 17. Participants with greater fine motor abilities
could draw shapes freehand and build three-dimensional
structures whereas three participants were unable to
turn pages or stack blocks.
The MABC-2 Parent Checklist provided a parent rating
of their child’s motor abilities in predictable and unpre-
dictable environments. In addition, a 13-item subscale
asks parents to indicate any non-motor factors that may
affect their child’s movement. Over 85% of parents in the
STXBP1 group reported that being overactive, distractible,
impulsive, disorganised, and hesitant contributed to their
child’s motor skills difficulties. In addition, 62.5% of chil-
dren became anxious in stressful, movement-related situa-
tions. All participants attempted MABC-2 motor tasks
but only one participant was able to complete the full
protocol enabling standardised scoring.
Current adaptive and communication abilities
The global adaptive function was estimated via the
Vineland Adaptive Behaviour Scales (parent interview)
composite score. Seven participants had scores in the
severe ID range and seven participants were in the mild
to moderate ID range. Notably, three participants under
2 years of age scored in the mild ID range, which may
indicate increasing diversion from developmental ex-
pectations with age.
Vineland Communication standard scores have a mean
of 100 and a standard deviation of 15. Participants scored
between 33 and 67 (i.e. moderately to severely impaired
range). The STXBP1 participants’ receptive abilities ranged
from an inability to listen and attend to speech to being
able to recall and carry out instructions given 5 min previ-
ously. Expressive ability ranged from difficulty with pre-
speech expression to engaging in interactive speech.
Current emotional and behavioural difficulties
The Developmental Behavioural Checklist (DBC) was
completed by parents to characterise the current behav-
ioural and emotional difficulties they observe in their
children (participants over the age of 5). Seven out of
eight STXBP1 participants had a DBC Total Problem
Behaviour Score above the clinical cut-off (T score 46)
indicative of the likely presence of psychopathology.
Behaviours such as biting, spitting, ripping things, hit-
ting, and running away from caregivers were common,
and parents reported demanding situations and frustra-
tion. Two parents remarked that these behaviours had
become increasingly difficult to manage following the
onset of puberty. High levels of anxiety associated with
specific causes such as fireworks, adverse weather,
hoovers, lawnmowers, and the emotions of others were
reported in five cases (4 females, 1 male). Six parents
also reported that their child rarely cried and did not ap-
pear to feel pain.
Parents completed the Conners Short Form to assess
the characteristics of ADHD and comorbid problems in
the sample. The STXBP1 group showed very elevated
scores on the inattention, hyperactivity, learning prob-
lems, and peer relations subscales. Two participants had
a T score in the normal range for executive functions
and five participants scored within the normal range on
the aggression subscale.
Current social functioning
Vineland socialisation subscale scores indicated that the
STXBP1 group demonstrate social adaptive impairments.
The Social Responsiveness Scale (SRS-2) was used to char-
acterise atypical social processes linked to autism spectrum
features in the sample. Three participants had an SRS total
score within the mild to moderately impaired range and
five scored above 76, which is indicative of severe social
impairment likely to meet criteria for an autism spectrum
diagnosis. Participants’ scores fell within the moderate to
severe range on social awareness, social cognition, social
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communication and restricted interests and repetitive
behaviours subscales. In contrast, scores on the social
motivation subscale were notably preserved and within the
normal range. Parents typically described a social profile
characterised by self-confidence in social settings and an
interest in engaging with peers and adults. The study
researchers also observed this strong interest in social inter-
action, despite limited communication and social skills as
assessed by Vineland scales.
Comparison of behavioural features in the STXBP1 full
dataset and ID groups
Motor function
There was no difference in gross motor skills between
groups as assessed via Vineland Adaptive Behaviour
Scales (Table 2) and Movement ABC (Table 3). However,
the STBXP1 group had poorer Vineland fine motor sub-
scale scores when compared to the ID group (U = 74.0,
p = 0.053). There was no difference between groups in
how parents evaluated the contextual factors influencing
children’s motor performance.
Emotional and behavioural difficulties
The STXBP1 and ID groups did not differ on DBC total
problem behaviour scores or subscale scores (stratified
for ID severity), indicating that emotional and behav-
ioural difficulties in general are not more prevalent or
severe in the STXBP1 group than expected for intellec-
tual disability due to other causes (Table 3). Anxiety and
disruptive behaviours were prominent problems for
some but not all individuals within the STXBP1 group;
however, group mean DBC anxiety subscale scores did
not differ from the ID comparison group. On the Con-
ners scales, the STXBP1 group were rated as significantly
more hyperactive/impulsive compared to the ID group
(U = 52.0, p = 0.026). In summary, the STXBP1 group
demonstrated similar total problem behaviour scores to
the ID comparison group, with variation within the
group in the severity and types of problems reported for
each individual. High hyperactivity/impulsivity scores
were more consistent within the STXBP1 group and on
average were more severe than reported for individuals
with other monogenic causes of ID.
Social functioning
There was a significant difference between STXBP1 and
the ID groups on Vineland Socialisation scores: the ID
group on average display stronger skills on all three
subscales—interpersonal relations, play and leisure, and
coping skills. The groups did not differ on SRS total score
or social awareness, social cognition, social communica-
tion and restricted interests and repetitive behaviours
(RRB) subscales. However, the ID comparison group were
more impaired on social motivation, compared to the
STXBP1 group who fell within the ‘normal’ range for this
subscale (U = 74.0, p = 0.06). In summary, the STXBP1
group demonstrated an atypical profile of social function-
ing in comparison to ID in general, with more severely im-
paired everyday social behaviour (on Vineland scales),
equivalently impaired social cognition (on SRS), but pre-
served social motivation.
Comparison of behavioural features in the STXBP1 full
dataset and low-ability ID groups
To explore the specificity of behavioural characteristics
associated with STXBP1 mutation in more detail, sec-
ondary comparisons were made to a subset of the ID
comparison group selected to match the range of global
adaptive abilities within the STXBP1 group. Although
the two groups had comparable global adaptive function
scores, communication impairments were more severe
in the STXBP1 group. The comparison group on average
demonstrated stronger receptive than expressive abilities
whereas the STXBP1 group showed severe restriction of
both receptive and expressive abilities (with significant
difference between groups in receptive score: U = 11.0,
p = 0.025). Groups did not differ in gross or fine motor
abilities. Behavioural problems assessed via the DBC
(total, subscales) did not differ between groups. The
STXBP1 group also did not differ from the low-ability
ID group in Conners hyperactivity or impulsivity scores,
indicating that although these difficulties are a consistent
problem area for the STXBP1 group, they are not more
impaired in these domains than other individuals with
equivalent global impairments. Comparison of Vineland
scores indicated that everyday social behaviours were
more impaired in the STXBP1 group in comparison to
the low-ability ID group (socialisation domain: U = 11.0,
p = 0.027, coping: U = 9.0, p = 0.014). The analysis of SRS
scores (see Fig. 1) indicated a stable pattern of results
whether comparing to the whole sample ID group or
low-ability ID group—total SRS scores did not differ,
social cognitive scores did not differ, restricted and re-
petitive behaviour scores did not differ, but social motiv-
ation was significantly preserved in the STXBP1 group
(U = 9.5, p = 0.018).
Discussion
In this study, we systematically assessed the behavioural
characteristics of children and adolescents with variants in
STXBP1, aiming to improve prognostication and manage-
ment for individuals with this rare genetic diagnosis. Par-
ticipants in the STXBP1 group demonstrated complex and
persistent difficulties across multiple domains of everyday
function and emotional-behavioural development. Con-
sistent problems within the group included severe com-
munication impairments and hyperactivity-impulsivity.
Some participants were greatly troubled by anxiety
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Table 3 Emotional and behavioural characteristics
Outcome measure Groups
STXBP1 full dataset (n = 8) ID all (n = 33) ID low ability (n = 8)
MABC parent checklist
Motor competence (static environments) Mean (SD) 24.5 (12.3) 18.45 (9.2) 23.00 (5.6)
Range 3–42 1–37 11–31
Motor competence (dynamic environments) Mean (SD) 26.00 (11.9) 22.12 (8.8) 25.5 (6.8)
Range 3–43 3–39 14–34
Total motor score Mean (SD) 50.5 (23.6) 40.61 (17.2) 48.5 (10.9)
Range 6–85 6–74 35–62
Conners (T score)
Inattention Mean (SD) 84.75 (7.5) 79.19 (12.0) 86.00 (5.3)
Range 72–92 55–90 79–90
Hyperactivity Mean (SD) 85.25 (6.5) 72.37 (15.0)# 77.25 (13.2)
Range 73–90 40–90 56–90
Learning problems Mean (SD) 86.38 (8.3) 79.44 (10.9) 86.13 (5.0)
Range 66–90 57–90 78–90
Executive functions Mean (SD) 76 (14.8) 64.56 (14.4) 66.25 (13.3)
Range 54–90 43–90 48–83
Aggression Mean (SD) 59.88 (17.4) 52.3 (10.5) 47.5 (4.8)
Range 44–90 44–83 44–58
Peer relations Mean (SD) 84.13 (7.2) 80.33 (15.0) 81.38 (16.1)
Range 72–90 45–90 45–90
DBC (percentile/stratified by ID severity)
Disruptive Mean (SD) 68.25 (24.3) 50.91 (28.8) 54.00 (25.2)
Range 28–90 4–98 26–90
Self-absorbed Mean (SD) 73.75 (19.2) 70.12 (25.8) 77.75 (17.9)
Range 34–94 10–100 40–100
Communication Mean (SD) 75.5 (17.8) 76.42 (23.1) 78.00 (18.8)
Range 48–96 6–100 40–92
Anxiety Mean (SD) 42.5 (24.5) 58.3 (26.9) 66.25 (30.1)
Range 12–76 10–100 10–96
Social relations Mean (SD) 49.5 (22.8) 58.85 (28.0) 57.00 (27.3)
Range 24–96 12–100 24–98
Total problems Mean (SD) 73.50 (24.1) 63.94 (27.4) 67.25 (22.3)
Range 30–94 0–100 38–98
SRS (T score)
Social awareness Mean (SD) 78.75 (5.9) 73.64 (11.2) 76.38 (12.3)
Range 70–87 49–93 56–92
Social cognition Mean (SD) 73.88 (11.5) 72.7 (11.0) 74.38 (6.6)
Range 53–92 47–96 67–85
Social communication Mean (SD) 76.25 (9.2) 72.7 (11.7) 80.88 (11.1)
Range 66–90 50–96 67–96
Social motivation Mean (SD) 58.00 (13.6) 64.52 (11.8) # 69.5 (13.6)#
Range 45–89 41–95 58–95
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including specific phobia, but these symptoms varied
across the group. We observed an additional contrast in
some individuals between low social anxiety and high
non-social anxiety. In view of moderate to severe ID, it is
important to consider whether behavioural characteristics
within this group differ from developmental expecta-
tions—we found that receptive language ability and social-
isation skills (but not hyperactivity) discriminated the
STXBP1 and ID comparison groups, suggesting a specific
contribution of aetiology to these features.
We were struck by a consistent profile of social behav-
iour within the STXBP1 group. Participants showed
great enjoyment of social interactions with family mem-
bers and demonstrated reciprocal behaviours such as
sharing and turn-taking. Researcher experience was that,
from the outset of the testing sessions, participants
wanted to engage with the researchers (a novel stranger
within the participants’ home) particularly in social ac-
tivities such as drawing, dancing, singing, and playing
games. Even participants as young as 2 years held eye
contact and were very sociable. On the other hand, par-
ental questionnaire ratings indicated limited understand-
ing of social expectations and difficulties integrating into
normal social settings. The observation of significantly
stronger social motivation remained true, whether com-
paring to the whole ID sample or low-ability ID sample,
indicating that this feature is not simply a correlate of
ID severity. Although several individuals scored above
cut-off on the SRS for a likely autism spectrum diagno-
sis, this profile of social behaviours would not be typical
Table 3 Emotional and behavioural characteristics (Continued)
Outcome measure Groups
STXBP1 full dataset (n = 8) ID all (n = 33) ID low ability (n = 8)
RRB Mean (SD) 79.00 (11.9) 78.36 (15.2) 87.38 (14.7)
Range 62–92 48–108 72–108
SRS total score Mean (SD) 77.75 (9.3) 75.12 (12.0) 81.75 (10.9)
Range 66–94 49–98 70–98
#Comparison to STXBP1 full dataset group, Mann-Whitney U test, P < 0.05
Fig. 1 Mean Social Responsiveness Scale subscale T scores in the STXBP1 and low-ability ID comparison groups
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for an individual with autism. These findings support
other research into the diverse social developmental tra-
jectories contributing to autism-like impairments in in-
dividuals with genomic disorders [31–33].
Epilepsy prevalence within the STXBP1 group was high,
as previously reported, but the type, severity, age of onset,
treatment sensitivity, and remission of seizures varied
across participants. A relatively high prevalence of focal sei-
zures was reported, in keeping with previous reports [7].
Further studies are needed to examine the contribution of
subclinical seizure activity to developmental progress for
individuals with STXBP1 variants, including interactions
between low-level sensory processing, cognitive biases, and
the social environment to mediate anxieties or prosocial
behaviour. In addition, comparison to other groups with
similar epilepsy prevalence and seizure characteristics could
tease apart aetiology-specific behavioural features from cor-
relates of, for example, focal seizures.
A further goal of this research is to stimulate future in-
vestigation of the mechanisms linking presynaptic dys-
function to cognitive and social development, which may
ultimately lead to aetiology-specific therapies. Toward this
goal, we compared our observations of the STXBP1 group
to published behavioural phenotyping studies of mice with
STXBP1mutations, to consider consistency across species.
The behavioural phenotypes exhibited across different
mice models include elevated anxiety, hyperactivity, and
impairments in acquiring and maintaining spatial memory
and reversal of previously learned strategies [25, 32, 34].
Importantly, not every aspect of learning and behaviour is
impaired: STXBP1 haploinsufficient mice demonstrate
normal sociability, preference for social novelty, and nor-
mal profiles of attentional control without impulsivity
[25]. In one study, social behaviours in STXBP1 mouse
models were examined by introducing a novel mouse into
the chamber [27]. Regardless of specific STXBP1 variant,
heterozygous mice spent more time around the novel
mouse and displayed normal sociability and preference for
social novelty. These findings appear, at least on the sur-
face, to be convergent with our observations of young
people with STXBP1 variants, and future research could
explore whether similar neurodevelopmental mechanisms
underpin social interactions across species.
In considering potential mechanisms underlying this
and other aspects of the STXBP1 phenotype, we have been
struck by the phenotypic similarity with Angelman syn-
drome (AS). AS is characterised by developmental delay,
seizure susceptibility including focal seizures, movement
disorders, language deficits, impulsivity, short attention
span, and specific phobias [33, 35–38]. The behavioural
hallmarks of AS are hyperactivity and hypersociability
[34]. Just as in STXBP1, individuals with AS display in-
creased social motivation, prolonged social interest, and
also excessive smiling and laughing [39]. Socialisation is
believed to be underpinned by a network of brain regions
including the amygdala, ventral striatum, orbital, and
ventromedial regions of the prefrontal cortex. However,
different regions and networks may have a greater role in
specific aspects of sociability [40]. It has been hypothe-
sised that reciprocal changes within striatal circuits give
rise to the atypical social novelty profile associated with
AS, consistent with experimental evidence for altered stri-
atal dopamine balance in a mouse model [41, 42]. Examin-
ing the striatum and its dependent functional neural
systems, in the context of the wider ‘social’ brain network,
may provide a starting point for understanding the neural
mechanisms driving the atypical social profile in STXBP1.
There are several important limitations to this study.
The sample size is small and encompasses a wide age
range. We aimed to ascertain participants as broadly as
possible, from multiple regions of the UK and multiple
medical specialties. In comparison to previous studies,
the STXBP1 participant group had a higher proportion
of individuals ascertained via clinical genetics rather
than paediatric neurology, which may provide a more
comprehensive picture of the phenotypic spectrum or
may under-represent individuals with early-onset epilep-
tic encephalopathy. The data were collected via parent
report, and it was not feasible to corroborate or elaborate
via review of medical records. It was also not feasible for
researchers collecting data to be blind to genetic diagno-
ses; however, our use of standardised parent-report
questionnaire measures should mitigate potential bias of
diagnosis-informed clinician ratings. Non-parametric stat-
istical analyses are included to enhance our descriptive
observations and provide an indication of which measures
may discriminate between groups. Given the small sample
size and large number of measures, adjusting the p value
threshold for statistical significance to account for mul-
tiple comparisons is not practical, and results should be
interpreted with due caution. The robustness of our find-
ings will, we hope, be tested in future independent studies
with pre-registered hypotheses and predictions building
on our exploratory results. In view of small sample size,
within-group analysis of behavioural variation was not jus-
tified (for example genotype-phenotype correlations, asso-
ciations with epilepsy severity or age of onset), and these
analyses would improve the prognostic utility of our
results. A further limitation of the current study is that we
have not directly assessed cognitive abilities in young
people with STXBP1 variants and are reliant on parent re-
port of adaptive function and behavioural characteristics.
To determine whether specific learning deficits character-
ise the disorder and contribute to behavioural characteris-
tics, it is necessary to accurately measure relevant aspects
of cognition in individuals with moderate to severe ID.
However, assessment of cognitive function in individuals
with AS or STXBP1 is challenging due to low levels of
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understanding and hyperactivity. To achieve this, cogni-
tive tasks must first be developed that assess the capacity
for learning different skills (rather than simply document-
ing deficits), are intuitive, and are developmentally appro-
priate. In addition to behavioural methods, application of
non-invasive physiological approaches such as wireless
EEG in semi-naturalistic settings may be feasible and in-
formative. These methods should be developed now and
applied in future once a larger number of individuals have
been diagnosed via genome-wide testing and can be
followed from early childhood through to adult life.
Conclusion
This research presents the post-diagnostic evaluation of
children and adolescents with STXBP1-associated neuro-
developmental disorder. Individuals with STXBP1 variants
have a wide range of complex adaptive, social and behav-
ioural characteristics. Via comparison to individuals with
other ID-related genetic diagnoses, we have highlighted a
more limited set of characteristics which may discriminate
individuals with STXBP1 from individuals with other
monogenic causes of neurodevelopmental disorder. Delin-
eating this spectrum should assist in recognising this dis-
order and supporting families after diagnosis. Moreover,
convergence between STXBP1 phenotypes across species
and across disorders (AS) provides a new starting point
for understanding the molecular and neural mechanisms
which underlie prosocial development.
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